The CJC-1295 & Ipamorelin blend combines two structurally different peptides that are studied together because they act on complementary pathways.
CJC-1295
CJC-1295 is a modified analog of growth-hormone-releasing hormone (GHRH). Amino-acid substitutions increase its resistance to enzymatic breakdown relative to native GHRH — a stability strategy discussed alongside amino acid sequences.
Ipamorelin
Ipamorelin is a short synthetic pentapeptide that mimics ghrelin at its receptor, valued in research for its selectivity. The two mechanisms are contrasted in CJC-1295 vs Ipamorelin and detailed in the blend's mechanism of action.
How they are made
Both are produced by solid-phase peptide synthesis and verified by HPLC and mass spectrometry.
Product page: CJC-1295 + Ipamorelin research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.